PRINT FRIENDLY

HBA Global presents

Part Two - United Against COVID-19: Answers from Italy and Insight from New York


Date and time
Tuesday, 14 April
12:00PM - 01:00PM EST
Location
Virtual

Event Contact
Emily Basca
610-213-9061
Competencies
8. Builds relationships and teams

Please note this webinar will take place from 12 – 1 PM ET. Please convert into your local time zone and mark your calendar accordingly.

As a follow-up to the incredible webinar with our HBA Milan and HBA Indianapolis leaders, the HBA community is coming together again during this challenging time to continue to learn from and support each other.

Our HBA community in Milan, Italy will answer questions submitted from part one in March and give an update on the current status of the coronavirus in Italy. In addition, HBA New York leaders will provide insight on the effect of the pandemic on their businesses.

Don’t miss the opportunity to hear how HBA members are coping professionally as business leaders and personally.

After registering, you will receive a confirmation email containing a link to cross-register on GoToWebinar. Once completed, you will receive information about joining the webinar.

This webinar was developed with input from and may include the following speakers:
    •  Maria Rompf, PhD, business development analyst, Roche Diabetes Care Indianapolis
    •  Annabella Amatulli, HBA Milan VP, regulatory affairs manager biotech and hi-tech, Dompé
    •  Simona Cristina Cardei, HBA Milan operations director, artwork coordinator team lead, Mylan
    •  Silvia Ceragioli, associate director, chemical development and manufacturing, Gilead
    •  Gaia Legori, regulatory affairs officer presso, Dompé
    •  Amalia Crescenzio, HBA Milan president, chief compliance officer, medical biotechnology, Dompé

Speakers from HBA New York will include:
    •  Michael O'Brien, HBA New York president, executive business coach, TEDx Speaker, author, Last Bad Day Creator
    •  Lisa S. Weiss, HBA New York operations director, senior director, clinical epidemiology, vaccines, Pfizer

Missed the webinar in March? No problem! The recording will be sent with the GoToWebinar instructions.

Registration information
Webinar is open to: HBA members and nonmembers
Online registration available until one hour before the live broadcast begins.

Featured speakers

Annabella  Amatulli
Global Regulatory Affairs Manager
Silvia  Ceragioli

Gilead Sciences
Amalia  Crescenzio

Dompé Farmaceutici s.p.a.
Gaia  Legori
Regulatory Affairs Officer
Michael  O'Brien
Resilience Expert - Executive Coach, Speaker, Author
Peloton Executive Coaching
Maria  Rompf
Business Development Manager
Roche Diagnostics
Lisa  Weiss
Independent Epidemiology Consultant
Pfizer Inc.
Learning Objectives
1. Collaborate with colleagues experiencing the effects of COVID-19 to appropriately respond as the pandemic spreads across the world.

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: Regular Registration

 Member$0.00
 Member - Euro€0.00
 Non-Member$15.00
 Non-Member - Euro€13.00
Collapse group

Registration: Site License

 Member$350.00
 Member - Euro€308.00
 Non-Member$350.00
 Non-Member - Euro€308.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.